[go: up one dir, main page]

FR2857592B1 - Nouveau procede de preparation de microparticules - Google Patents

Nouveau procede de preparation de microparticules

Info

Publication number
FR2857592B1
FR2857592B1 FR0308799A FR0308799A FR2857592B1 FR 2857592 B1 FR2857592 B1 FR 2857592B1 FR 0308799 A FR0308799 A FR 0308799A FR 0308799 A FR0308799 A FR 0308799A FR 2857592 B1 FR2857592 B1 FR 2857592B1
Authority
FR
France
Prior art keywords
microparticles
preparation
new process
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0308799A
Other languages
English (en)
Other versions
FR2857592A1 (fr
Inventor
Guylaine Ronsse
Nathalie Mondoly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0308799A priority Critical patent/FR2857592B1/fr
Priority to PCT/FR2004/001871 priority patent/WO2005009415A2/fr
Priority to ARP040102523 priority patent/AR045915A1/es
Publication of FR2857592A1 publication Critical patent/FR2857592A1/fr
Application granted granted Critical
Publication of FR2857592B1 publication Critical patent/FR2857592B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0308799A 2003-07-18 2003-07-18 Nouveau procede de preparation de microparticules Expired - Fee Related FR2857592B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0308799A FR2857592B1 (fr) 2003-07-18 2003-07-18 Nouveau procede de preparation de microparticules
PCT/FR2004/001871 WO2005009415A2 (fr) 2003-07-18 2004-07-16 Nouveau procede de preparation de microparticules
ARP040102523 AR045915A1 (es) 2003-07-18 2004-07-16 Metodo para preparar microparticulas y microparticulas obtenidas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0308799A FR2857592B1 (fr) 2003-07-18 2003-07-18 Nouveau procede de preparation de microparticules

Publications (2)

Publication Number Publication Date
FR2857592A1 FR2857592A1 (fr) 2005-01-21
FR2857592B1 true FR2857592B1 (fr) 2006-02-24

Family

ID=33548252

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0308799A Expired - Fee Related FR2857592B1 (fr) 2003-07-18 2003-07-18 Nouveau procede de preparation de microparticules

Country Status (3)

Country Link
AR (1) AR045915A1 (fr)
FR (1) FR2857592B1 (fr)
WO (1) WO2005009415A2 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929405A (en) * 1958-12-22 1963-06-19 Upjohn Co Processes for the encapsulation of particles
IL92344A0 (en) * 1989-01-04 1990-07-26 Gist Brocades Nv Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
WO1995003789A1 (fr) * 1993-07-28 1995-02-09 The Johns Hopkins University School Of Medicine Liberation regulee de substances pharmaceutiquement actives provenant de microcapsules de coacervat
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
AU5441199A (en) * 1998-09-01 2000-03-21 Elan Corporation, Plc Oral vaccine compositions
US6488870B1 (en) * 2000-11-27 2002-12-03 Xerox Corporation Encapsulation process

Also Published As

Publication number Publication date
WO2005009415A3 (fr) 2005-04-07
FR2857592A1 (fr) 2005-01-21
AR045915A1 (es) 2005-11-16
WO2005009415A2 (fr) 2005-02-03

Similar Documents

Publication Publication Date Title
EP1591438A4 (fr) Procede de preparation de 4-aminodiphenylamine
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
CR8226A (es) Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
NO20053796D0 (no) Process for the production of particles
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
MA26407A1 (fr) Procede de preparation de combretastatines
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
FI20030383A0 (fi) Menetelmä katalyytin valmistamiseksi
EP1752464A4 (fr) Procede de preparation de timosaponine b ii
FR2873372B1 (fr) Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
EP1593459A4 (fr) Procede de meulage
EP1547993A4 (fr) Procede de preparation de spirofluorenols
EP1629833A4 (fr) Procede pour produire des microparticules
FR2876998B1 (fr) Procede de preparation de gamma-liv205
NO20034597D0 (no) Fremgangsmåte for fremstilling av cantaxantin
EP1646640A4 (fr) Procede pour la preparation de derives de 1-androstene hautement purs
EP1682627A4 (fr) Procede de preparation de methyllithium
MY136695A (en) Process for the preparation of alkylaryl compounds
EP1477477A4 (fr) Procede de preparation de carotenoides
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
FR2857592B1 (fr) Nouveau procede de preparation de microparticules
FR2894958B1 (fr) Procede de preparation de difluoroethanol
ITMI20041941A1 (it) Processo per la preparazione di lisofosfatidilcoline
EP1858851A4 (fr) Procede de preparation de la lercanidipine amorphe

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20140331